Gene Composition as a Potential Barrier to Large Recombinations in the Bacterial Pathogen Klebsiella pneumoniae.


Journal

Genome biology and evolution
ISSN: 1759-6653
Titre abrégé: Genome Biol Evol
Pays: England
ID NLM: 101509707

Informations de publication

Date de publication:
01 11 2019
Historique:
accepted: 25 10 2019
pubmed: 31 10 2019
medline: 24 3 2020
entrez: 31 10 2019
Statut: ppublish

Résumé

Klebsiella pneumoniae (Kp) is one of the most important nosocomial pathogens worldwide, able to cause multiorgan infections and hospital outbreaks. One of the most widely disseminated lineage of Kp is the clonal group 258 (CG258), which includes the highly resistant "high-risk" sequence types ST258 and ST11. Genomic investigations revealed that very large recombination events have occurred during the emergence of Kp lineages. A striking example is provided by ST258, which has undergone a recombination event that replaced over 1 Mb of the genome with DNA from an unrelated Kp donor. Although several examples of this phenomenon have been documented in Kp and other bacterial species, the significance of these very large recombination events for the emergence of either hypervirulent or resistant clones remains unclear. Here, we present an analysis of 834 Kp genomes that provides data on the frequency of these very large recombination events (defined as those involving >100 kb), their distribution within the genome, and the dynamics of gene flow within the Kp population. We note that very large recombination events occur frequently, and in multiple lineages, and that the majority of recombinational exchanges are clustered within two overlapping genomic regions, which have been involved by recombination events with different frequencies. Our results also indicate that certain lineages are more likely to act as donors to CG258. Furthermore, comparison of gene content in CG258 and non-CG258 strains agrees with this pattern, suggesting that the success of a large recombination depends on gene composition in the exchanged genomic portion.

Identifiants

pubmed: 31665331
pii: 5609113
doi: 10.1093/gbe/evz236
pmc: PMC6865855
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3240-3251

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of the Society for Molecular Biology and Evolution.

Références

Bioinformatics. 2012 Jun 1;28(11):1536-7
pubmed: 22495750
Methods Mol Biol. 2009;537:113-37
pubmed: 19378142
Antimicrob Agents Chemother. 2015 Jan;59(1):389-96
pubmed: 25367909
Antimicrob Agents Chemother. 2015 Oct;59(10):5873-84
pubmed: 26169401
Nucleic Acids Res. 2011 Jul;39(Web Server issue):W347-52
pubmed: 21672955
Bioinformatics. 2015 Nov 15;31(22):3691-3
pubmed: 26198102
Genome Biol Evol. 2015 Apr 10;7(5):1267-79
pubmed: 25861820
Bioinformatics. 2014 May 1;30(9):1312-3
pubmed: 24451623
Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):4988-93
pubmed: 24639510
MBio. 2014 Jun 24;5(3):e01355-14
pubmed: 24961694
Environ Microbiol. 2004 Jun;6(6):584-90
pubmed: 15142246
Proc Natl Acad Sci U S A. 2015 Jul 7;112(27):E3574-81
pubmed: 26100894
Syst Appl Microbiol. 2004 Feb;27(1):27-35
pubmed: 15053318
Nucleic Acids Res. 2002 Jun 1;30(11):2478-83
pubmed: 12034836
Antimicrob Agents Chemother. 2013 Jan;57(1):130-6
pubmed: 23070171
Emerg Infect Dis. 2014 Nov;20(11):1812-20
pubmed: 25341126
Genome Res. 2004 Jul;14(7):1394-403
pubmed: 15231754
Cold Spring Harb Perspect Biol. 2016 Jul 01;8(7):
pubmed: 27091940
MBio. 2014 Jul 29;5(4):e01550-14
pubmed: 25073645
PLoS Comput Biol. 2015 Feb 12;11(2):e1004041
pubmed: 25675341
Bioinformatics. 2006 Jun 15;22(12):1540-2
pubmed: 16595560
Curr Protoc Bioinformatics. 2010 Sep;Chapter 11:Unit 11.5
pubmed: 20836074
BMC Bioinformatics. 2010 Mar 08;11:119
pubmed: 20211023
Antimicrob Agents Chemother. 2014 May;58(5):2961-3
pubmed: 24566171
PLoS One. 2015 Jul 21;10(7):e0133727
pubmed: 26196384
Nucleic Acids Res. 2016 Jan 4;44(D1):D733-45
pubmed: 26553804
MMWR Morb Mortal Wkly Rep. 2017 Jan 13;66(1):33
pubmed: 28081065
Int J Syst Evol Microbiol. 2014 Sep;64(Pt 9):3146-52
pubmed: 24958762
Bioinformatics. 2014 Jul 15;30(14):2068-9
pubmed: 24642063
Mol Biol Evol. 2009 Jul;26(7):1641-50
pubmed: 19377059
Clin Microbiol Infect. 2012 May;18(5):413-31
pubmed: 22507109
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D32-6
pubmed: 16381877
Ann Clin Microbiol Antimicrob. 2014 May 01;13:16
pubmed: 24884610

Auteurs

Francesco Comandatore (F)

Sky Net UNIMI Platform - Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, Dipartimento di Scienze Biomediche e Cliniche Luigi Sacco, Università degli Studi di Milano, Italy.

Davide Sassera (D)

Department of Biology and Biotechnology L. Spallanzani, Universita' degli Studi di Pavia, Italy.

Sion C Bayliss (SC)

Milner Centre for Evolution, Department of Biology and Biochemistry, University of Bath, United Kingdom.

Erika Scaltriti (E)

Risk Analysis and Genomic Epidemiology Unit, Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia-Romagna, Parma, Italy.

Stefano Gaiarsa (S)

U.O.C. Microbiologia e Virologia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Xiaoli Cao (X)

Department of Laboratory Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, People's Republic of China.

Ana C Gales (AC)

Laboratório ALERTA, Division of Infectious Diseases, Department of Internal Medicine, Escola Paulista de Medicina - EPM, Universidade Federal de São Paulo (UNIFESP), Brazil.

Ryoichi Saito (R)

Department of Molecular Microbiology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.

Stefano Pongolini (S)

Risk Analysis and Genomic Epidemiology Unit, Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia-Romagna, Parma, Italy.

Sylvain Brisse (S)

Institut Pasteur, Biodiversity and Epidemiology of Bacterial Pathogens, Paris, France.

Edward J Feil (EJ)

Milner Centre for Evolution, Department of Biology and Biochemistry, University of Bath, United Kingdom.

Claudio Bandi (C)

Sky Net UNIMI Platform - Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, Dipartimento di Bioscienze, Università degli Studi di Milano, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH